AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glitaray M Plus 4mg/850mg Tablet

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Glimepiride (4mg) + Metformin (850mg)

Overview Glitaray M Plus 4mg/850mg Tablet

Diabex Duo 4mg/850mg tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are crucial for prevention. Alcohol consumption should be minimized due to its hypoglycemic risk. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function are recommended by your doctor.

Primary Ingredients of Glitaray M Plus 4mg/850mg Tablet

The provided text is "undefined," which lacks meaning and cannot be rephrased.

Uses of Glitaray M Plus 4mg/850mg Tablet

Managing type 2 diabetes

Major Benefits of Glitaray M Plus 4mg/850mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the 4mg/850mg Glitaray M Plus Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Glitaray M Plus 4mg/850mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitaray M Plus 4mg/850mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glitaray M Plus 4mg/850mg Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

How Glitaray M Plus 4mg/850mg Tablet works:

Each Glitaray M Plus 4mg/850mg tablet combines glimepiride (a sulfonylurea) and metformin (a biguanide), two medications used to manage diabetes. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin works through a triple action: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Glitaray M Plus 4mg/850mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitaray M Plus 4mg/850mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding mothers should avoid Glitaray M Plus 4mg/850mg Tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glitaray M Plus 4mg/850mg tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. The use of Glitaray M Plus 4mg/850mg tablets is contraindicated in patients exhibiting severe kidney disease. Regular assessment of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glitaray M Plus 4mg/850mg Tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically recommended for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glitaray M Plus 4mg/850mg Tablet :

Should you forget to take a Glitaray M Plus 4mg/850mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaray M Plus 4mg/850mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glitaray M Plus 4mg/850mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glitaray M Plus 4mg/850mg Tablets can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glitaray M Plus 4mg/850mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glitaray M Plus 4mg/850mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glitaray M Plus 4mg/850mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental Vitamin B12 intake is recommended by some researchers.
Glitaray M Plus 4mg/850mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glitaray M Plus 4mg/850mg Tablet with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glitaray M Plus 4mg/850mg...
105
MRP 122
13% off